1. Konarski W, Poboży T, Śliwczyński A, Kotela I, Krakowiak J, Hordowicz M, et al. Avascular Necrosis of Femoral Head-Overview and Current State of the Art. Int J Environ Res Public Health. 2022;19:7348.

https://doi.org/10.3390/ijerph19127348

PMid:35742595 PMCid:PMC9223442

2. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kade-mani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Med-ication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2022;80:920-43.

https://doi.org/10.1016/j.joms.2022.02.008

PMid:35300956 

3. Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020;110:102460.

https://doi.org/10.1016/j.jaut.2020.102460

PMid:32307211 

4. Laputková G, Talian I, Schwartzová V. Medication-Related Osteonecrosis of the Jaw: A Systematic Review and a Bioinformatic Analysis. Int J Mol Sci. 2023;24:16745.

https://doi.org/10.3390/ijms242316745

PMid:38069068 PMCid:PMC10706386

5. Ramos EU, Bizelli VF, Pereira Baggio AM, Ferriolli SC, Silva Prado GA, Farnezi Bassi AP. Do the new protocols of platelet-rich fibrin centrifugation allow better control of postoperative complications and healing after surgery of impacted lower third molar? A systematic review and meta-analysis. J Oral Maxillofac Surg [Internet]. 2022;80:1238-53.

https://doi.org/10.1016/j.joms.2022.03.011

PMid:35439437 

6. Teixeira S, Branco L, Fernandes MH, Costa-Rodrigues J. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects. Mini Rev Med Chem. 2019;19:988-98.

https://doi.org/10.2174/1389557519666190424163044

PMid:31020940 

7. Barik D, Dash P, Uma PI, Kumari S, Dash M. A Review on Re-Packaging of Bisphosphonates Using Biomaterials. J Pharm Sci. 2021;110:3757-72.

https://doi.org/10.1016/j.xphs.2021.08.028

PMid:34474062 

8. Dziegielewski PT, Bernard S, Mendenhall WM, Hitchock KE, Parker Gibbs C, Wang J, et al. Osteoradionecrosis in osseous free flap reconstruction: Risk factors and treatment. Head Neck. 2020;42:1928-38.

https://doi.org/10.1002/hed.26118

PMid:32134160 

9. Drudge-Coates L, Van den Wyngaert T, Schiødt M, van Muilekom HAM, Demonty G, Otto S. Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Supportive Care in Cancer. 2020;28:4019-29.

https://doi.org/10.1007/s00520-020-05440-x

PMid:32307659 PMCid:PMC7378104

10. Pardo-Zamora G, Martínez Y, Moreno JA, Ortiz-Ruíz AJ. Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series. Int J Environ Res Public Health. 2021;18:1018.

https://doi.org/10.3390/ijerph18031018

PMid:33498884 PMCid:PMC7908594

11. Lorenzo-Pouso AI, Bagán J, Bagán L, Gándara-Vila P, Chamorro-Petronacci CM, Castelo-Baz P, et al. Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review. J Clin Med. 2021;10:4367.

https://doi.org/10.3390/jcm10194367

PMid:34640383 PMCid:PMC8509366

12. Cano-Durán JA, Peña-Cardelles JF, Ortega-Concepción D, Paredes-Rodríguez VM, García-Riart M, López-Quiles J. The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ). J Clin Exp Dent. 2017;9:e1051-9.

https://doi.org/10.4317/jced.54154

PMid:28936298 PMCid:PMC5601107

13. Serafini G, Lollobrigida M, Fortunato L, Mazzucchi G, Lamazza L, Di Nardo D, et al. Postextractive Alveolar Ridge Preservation Using L-PRF: Clinical and Histological Evaluation. Case Rep Dent. 2020;2020:5073519.

https://doi.org/10.1155/2020/5073519

PMid:32577315 PMCid:PMC7306078

14. Nowak SM, Sacco R, Mitchell FL, Patel V, Gurzawska-Comis K. The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review. J Cranio-Maxillo-fac Surg Off Publ Eur Assoc Cranio-Maxillo-fac Surg. 2024;52:671-91.

https://doi.org/10.1016/j.jcms.2024.01.007

PMid:38644092 

15. Salgado-Peralvo ÁO, Kewalramani N, Pérez-Jardón A, Pato-Mourelo J, Castro-Calderón A, Arriba-Fuente L, et al. Understanding Solid-Based Platelet-Rich Fibrin Matrices in Oral and Maxillofacial Surgery: An Integrative Review of the Critical Protocol Factors and Their Influence on the Final Product. Med Kaunas Lith. 2023;59:1903.

https://doi.org/10.3390/medicina59111903

PMid:38003952 PMCid:PMC10673335

16. Bennardo F, Barone S, Antonelli A, Giudice A. Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw. Periodontol 2000. 2025;97:287-307.

https://doi.org/10.1111/prd.12608

PMid:39345044 PMCid:PMC11808450

17. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int J Surg. 2014;12:1495-9.

https://doi.org/10.1016/j.ijsu.2014.07.013

PMid:25046131 

‌18. Hamzani Y, Chaushu G. Evaluation of early wound healing scales/indexes in oral surgery: A literature review. Clinical Implant Dentistry and Related Research. 2018;20:1030-5

https://doi.org/10.1111/cid.12680

PMid:30324746 

19. Del Corso M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol. 2012;13:1207-30.

https://doi.org/10.2174/138920112800624391

PMid:21740371 

20. Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, et al. Regenerative potential of leucocyte- and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation and implant therapy. A systematic review. J Clin Periodontol. 2017;44:225-34.

https://doi.org/10.1111/jcpe.12658

PMid:27891638 PMCid:PMC5347939

21. Dohan Ehrenfest DM, Pinto NR, Pereda A, Jiménez P, Corso MD, Kang BS, et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets. 2018;29:171-84.

https://doi.org/10.1080/09537104.2017.1293812

PMid:28437133 

22. Temmerman A, Vandessel J, Castro A, Jacobs R, Teughels W, Pinto N, et al. The use of leucocyte and platelet-rich fibrin in socket management and ridge preservation: a split-mouth, randomized, controlled clinical trial. J Clin Periodontol. 2016;43:990-9.

https://doi.org/10.1111/jcpe.12612

PMid:27509214 

23. Almeida Barros Mourão CF, de Mello-Machado RC, Javid K, Moraschini V. The use of leukocyte- and platelet-rich fibrin in the management of soft tissue healing and pain in post-extraction sockets: A randomized clinical trial. J Cranio-Maxillo-fac Surg Off Publ Eur Assoc Cranio-Maxillo-fac Surg. 2020;48:452-7.

https://doi.org/10.1016/j.jcms.2020.02.020

PMid:32201062 

24. Ding ZY, Tan Y, Peng Q, Zuo J, Li N. Novel applications of platelet concentrates in tissue regeneration (Review). Exp Ther Med. 2021;21:226.

https://doi.org/10.3892/etm.2021.9657

PMid:33603835 PMCid:PMC7851614

25. Muñoz-Salgado A, Silva FF, Padín-Iruegas ME, Camolesi GC, Bernaola-Paredes WE, Veronese HR, et al. Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28:e317-29.

https://doi.org/10.4317/medoral.25733

PMid:36641740 PMCid:PMC10314351

26. Yalcin-Ülker GM, Duygu G, Tanan G, Cakir M, Meral DG. Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw. J Craniofac Surg. 2023;34:1039-44.

https://doi.org/10.1097/SCS.0000000000009161

PMid:36627754 

27. Tenore G, Zimbalatti A, Rocchetti F, Graniero F, Gaglioti D, Mohsen A, et al. Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J Clin Med. 2020;9:3505.

https://doi.org/10.3390/jcm9113505

PMid:33138266 PMCid:PMC7693575

28. Roman RC, Moldovan MA, Pop LS, Megieșan S, Faur CI. Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis. J Clin Med. 2024;13:3473.

https://doi.org/10.3390/jcm13123473

PMid:38930013 PMCid:PMC11204677

29. Inchingolo F, Cantore S, Dipalma G, Georgakopoulos I, Almasri M, Gheno E, et al. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation. J Biol Regul Homeost Agents. 2017;31:811-6.

PMid:28958140

30. Al-Hamed FS, Mahri M, Al-Waeli H, Torres J, Badran Z, Tamimi F. Regenerative Effect of Platelet Concentrates in Oral and Craniofacial Regeneration. Front Cardiovasc Med. 2019;6:126.

https://doi.org/10.3389/fcvm.2019.00126

PMid:31552270 PMCid:PMC6733887

31. Canellas JVDS, Medeiros PJD, Figueredo CMDS, Fischer RG, Ritto FG. Platelet-rich fibrin in oral surgical procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2019;48:395-414.

https://doi.org/10.1016/j.ijom.2018.07.007

PMid:30072300